In Thailand Colon cancer is noted to be the 3rd in females and 4th most common in males. If colon cancer is found in the early stages, 9 of 10 patients have a chance to survive more than 5 years.
Early tect is a new non-invasive method for colorectal cancer screening which has high sensitivity and specificity up to 90.2%. It’s a stool DNA-based testing to detect “SDC-2 biomarker methylation” which is expressed in all stages of colon cancer including pre-cancerous lesions such as polyps and tumor.
- Clients aged 30 – 80 years old
- People at risk of colon cancer such as ulcerative colitis, chronic ulcerative colitis, Crohn’s disease, family colon polyposis, and family history of colorectal cancer
- Alcohol drinking, meat or animal products lovers, smoking and obesity
